Filing excerpt
On June 24, 2026, we acquired 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for a net consideration paid of $950 million.
Source: Autobound Signal API · 103 signals tracked for Agilent · updated
Get Agilent's live signals in Claude or ChatGPT, or by API
What changed at Agilent this week? Use Autobound signals for agilent.com.Agilent acquired 100 percent of the outstanding capital stock of Biocare for net consideration of $950 million to expand its pathology portfolio within the Life Sciences and Diagnostics Markets segment.
Filing excerpt
On June 24, 2026, we acquired 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for a net consideration paid of $950 million.
What this signalsIntegration work after a deal often opens needs for new systems and services.
sec-10qacquisitionCompletedGet every 10-Q signal for Agilent and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Agilent this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/0d67134a-8f3b-4461-8c77-ce34fd27d04b returns this record as JSON. POST /v1/companies/enrich returns every signal for agilent.com.
{
"signal_id": "0d67134a-8f3b-4461-8c77-ce34fd27d04b",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-11-09T06:34:41.459+00:00",
"company": {
"name": "Agilent",
"domain": "agilent.com"
},
"data": {
"detail": "Agilent acquired 100 percent of the outstanding capital stock of Biocare for net consideration of $950 million to expand its pathology portfolio within the Life Sciences and Diagnostics Markets segment. Vendors offering integration, laboratory workflow, and post-merger systems alignment may find opportunities.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "net consideration paid to acquire 100 percent of the outstanding capital stock of BC Midco I, Inc. (Biocare)",
"dollar_millions": 950
},
"quarter": "Q3",
"summary": "Agilent Completed $950 Million Acquisition of BC Midco I, Inc. (Biocare) on June 24, 2026",
"excerpts": "On June 24, 2026, we acquired 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for a net consideration paid of $950 million.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1090872/000109087226000064/a-20260731.htm",
"filing_date": "2026-09-01",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "07/31",
"period_end_date": "2026-07-31",
"sales_relevance": "Active integration needs",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/0d67134a-8f3b-4461-8c77-ce34fd27d04b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"agilent.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.